Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0057 | 0.9 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |